Budget Amount *help |
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Research Abstract |
We developed a new vaccine, which was constitute of influeza M2 angigen and SF10 a synthetic adjuvant that mimics pulmonary surfactant. Fluoresceinated M2 delivery to cultured dendritic cells was significantly enhanced by co-administration of SF10. And intranasal immunization of M2-SF10 enhanced local and systemic immune responses, compared with those induced by M2 antigen alone.
|